General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct‐acting antiviral therapy

BACKGROUND AND AIM: To validate a composite predictive model for hepatocellular carcinoma (HCC) development in patients with advanced liver fibrosis associated with chronic hepatitis C virus (HCV) who have received direct‐acting antiviral (DAA) therapy and achieved sustained virologic response (SVR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Tada, Toshifumi, Kurosaki, Masayuki, Tamaki, Nobuharu, Yasui, Yutaka, Mori, Nami, Tsuji, Keiji, Hasebe, Chitomi, Joko, Koji, Akahane, Takehiro, Furuta, Koichiro, Kobashi, Haruhiko, Fujii, Hideki, Ishii, Toru, Marusawa, Hiroyuki, Kondo, Masahiko, Kojima, Yuji, Yoshida, Hideo, Uchida, Yasushi, Nakamura, Shinichiro, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260214/
https://www.ncbi.nlm.nih.gov/pubmed/35822118
http://dx.doi.org/10.1002/jgh3.12778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260214/
https://www.ncbi.nlm.nih.gov/pubmed/35822118
http://dx.doi.org/10.1002/jgh3.12778

Ejemplares similares